|
|
||||||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
1-induced Epithelial-to-Mesenchymal Transition in MDCK Cells
1 Medicine, University of Utah and Veterans Affairs Medical Center, Salt Lake City, Utah, United States
2 Cellular Biology and Anatomy, Medical College of Georgia, United States; Medical Research Service, Veterans Affairs Medical Center, United States
* To whom correspondence should be addressed. E-mail: tianxin.yang{at}hsc.utah.edu.
In a separate study, we identified PGE2 as a potent inhibitor of TGF-
1-induced epithelial-mesenchymal transition (EMT) in cultured Madin-Darby canine kidney (MDCK) cells. This finding prompted us to examine the roles of other prostanoids: PGD2, PGF2
, PGI2, and thromboxane A2 (TXA2). Treatment with 10 ng/ml TGF-
1 for 3 days induced EMT as reflected by conversion to the spindle-like morphology, loss of E-cadherin, and activation of
-smooth muscle actin (
-SMA). Treatment with PGD2 remarkably preserved the epithelial-like morphology, restored the expression of E-cadherin, and abolished the activation of
-SMA. In contrast, PGF2
, carbocyclic thromboxane A2 , PGI2 and its stable analog beraprost, were without an effect. MDCK cells expressed DP1 and DP2 receptors, however, the effect of PGD2 was neither prevented by DP1 antagonist BW-A868C or DP2 antagonist BAY-u3405, nor was mimicked by DP1 agonist BW245C. cAMP-elevating agents forskolin and 8-Br-cAMP blocked EMT. However, cAMP blockers H89 and Rp-cAMP failed to block the effect of PGD2. PGD2 did not seem to act via its metabolites as 15-deoxy-Delta(12,14)-prostaglandin J2 (15d-PGJ2) levels in the medium following incubation with 3 µM PGD2 were well below the values predicted from the cross activity of the assay. Exposure to TGF-
1 induced a three-fold increase in ROS production that was completely abolished by PGD2. We conclude that: 1) PGD2, but not PGI2, PGF2
, and TXA2 inhibit EMT; 2) PGD2 inhibits EMT independently of DP1 and DP2 receptors, and 3) PGD2 exhibits anti-oxidant property which may in part account for the anti-fibrotic action of this PG.
This article has been cited by other articles:
![]() |
E. Kolosionek, R. Savai, H. A. Ghofrani, N. Weissmann, A. Guenther, F. Grimminger, W. Seeger, G. A. Banat, R. T. Schermuly, and S. S. Pullamsetti Expression and Activity of Phosphodiesterase Isoforms during Epithelial Mesenchymal Transition: The Role of Phosphodiesterase 4 Mol. Biol. Cell, November 15, 2009; 20(22): 4751 - 4765. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Huang, A. Zhang, G. Ding, and R. Chen Aldosterone-induced mesangial cell proliferation is mediated by EGF receptor transactivation Am J Physiol Renal Physiol, June 1, 2009; 296(6): F1323 - F1333. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. Ding, A. Zhang, S. Huang, X. Pan, G. Zhen, R. Chen, and T. Yang ANG II induces c-Jun NH2-terminal kinase activation and proliferation of human mesangial cells via redox-sensitive transactivation of the EGFR Am J Physiol Renal Physiol, December 1, 2007; 293(6): F1889 - F1897. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH |
| Visit Other APS Journals Online |